Brief Report on Use of Pembrolizumab With or Without Chemotherapy for Advanced Lung Cancer: A Real-World Analysis.

Competing Interests: Disclosure Shirish Gadgeel has served on advisory boards for Merck, Blueprint, Gilead, Novartis, BMS, Genentech/Roche, Astra-Zeneca, Mirati, Daichii, Takeda, and Pfizer. Monika Izano, Chenan Zhang, Connor Sweetnam, Frank Wolf, Mary Tran, and Thomas Brown are all employees and stockholders of Syapse. Andrew Stafford was employed by Syapse at the time the study was conducted. James Weese, Douglas Reding, Jonathan Treisman, Anand Patel, and Bindu Potugari have no conflicts to disclose.